Taking a data-based approach allows companies to proactively identify issues, remove any supply chain-related bottlenecks and reduce significantly the time to market.
N-SIDE recently optimized the clinical trials manufacturing plan for a key biological compound with limited manufacturing resources. With the optimized plan, the biotech company was able to speed up the recruitment for multiple studies and add a new Phase 3 trial to the program. Download the whitepaper for details.